Discussion forum for Pharma Quality events, Regulatory Actions
Warning letters, 483s, Recalls, Import Alerts, Audit observations
Warning letters, 483s, Recalls, Import Alerts, Audit observations
Hospira recalled in US one lot of 4.2% Sodium bicarbonate injection and one lot each of 1% and 2% Lidocaine HCl injections for potential presence of glass particulate matter. Potential complications of particulate matter in the injections include inflammation of a vein, granuloma, and blockage of blood vessels or life-threatening blood clot events.
Leave a Comment
You must be logged in to post a comment.